Peer-reviewed Publications (Original research)

Peer-reviewed Publications (Original research)

• Inoue K, Athey S, Tsugawa Y. (2023). Machine-learning-based high-benefit approach versus conventional high-risk approach in blood pressure management. Int J Epidemiology 52(4):1243-1256
• Inoue K, Tsugawa Y, Mayeda ER, Ritz B. (2023). Association of Daily Step Patterns with Mortality in US adults. JAMA Network Open 6(3):e235174
• Naito T, Inoue K, Sonehara K, etc. (2023). Genetic risk of primary aldosteronism and its contribution to hypertension: a cross-ancestry meta-analysis of genome-wide association study. Circulation 147(14):1097-1109
• Inoue K, Kondo N, Sato K, Fukuma S (2023). Trends in Cardiovascular Risk Factors by Income among Japanese Adults Aged 30-49 Years from 2017-2020: A nationwide longitudinal cohort study. Endocrine Practice 29(3):185-192
• Yoshihara A, Noh JY, Inoue K, et al. (2023). Incidence of and Risk Factors for Neonatal Hypothyroidism among Women with Graves’ Disease Treated with Antithyroid Drugs until Delivery.Thyroid 33(3):373-379
• Inoue K, Seeman T, Horwich T, Budoff M, Watson KE (2022). Heterogeneity in the Association Between the Presence of Coronary Artery Calcium and Cardiovascular Events: A Machine Learning Approach in the MESA Study. Circulation 147(2):132-141
• Inoue K, Rong G, Lee ML, Ebrahimi R, Neverova N, Currier J, Bashir M, Leung AM (2022). Iodinated Contrast Administration and Risks of Thyroid Dysfunction: A Retrospective Cohort Analysis of the U.S. Veterans Health Administration System. Thyroid 33(2):230-238
• Kato H, Hoshino Y, Hidaka N, Ito N, Makita N, Nangaku M, Inoue K. (2022). Machine Learning-Based Prediction of Elevated PTH Levels Among the US General Population. Journal of Clinical Endocrinology and Metabolism 107(12):3222-3230
• Mori Y, Duru OK, Tuttle K, Fukuma S, Taura D, Harada N, Inagaki N, Inoue K. (2022). Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism 108(1):221-231
• Inoue K, Haseda M, Shiba K, Tsuji T, Kondo K, Kondo N. (2022). Social Isolation and Depressive Symptoms Among Older Adults: A Multiple Bias Analysis Using a Longitudinal Study in Japan. Annals of Epidemiology 77:110-118
• Inoue K, Figueroa F, Kondo N, Tsugawa Y (2022). Changes in Industry Marketing Payments to Physicians during the COVID-19 pandemic: Quasi-experimental Difference-in-difference Study. BMJ Medicine; 1(1)
• Suzuki N, Inoue K (co-first), Noh JY, et al (2022). The Mediation Role of TRAb in the Relationship between Age and Severity of Hyperthyroidism in Graves’ Disease. Thyroid 32(10):1243-1248
• Inoue K, Watson KE, Kondo N, Horwich T, Hsu W, Bui A, Duru OK. (2022). Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race. JAMA Network Open; 1;5(3):e222037
• Inoue K, Ritz B, Arah OA. (2022). Causal Effect of Chronic Pain on Mortality through Opioid prescriptions: An Application of the Front-Door Formula. Epidemiology;33(4):572-580
• Inoue K, Goto A, Kondo N, Shinozaki T. (2022). Bias amplification in the g-computation algorithm for time-varying treatments: a case study of industry payments and prescription of opioid products. BMC Medical Research Methodology; 22(1):120.
• Inoue K, Horikoshi H, Omura M, Tsurutani Y, Saito J, Nishikawa T (2022). Association between aldosterone and hypertension among patients with overt and subclinical hypercortisolism. Journal of Endocrine Society 7(1):bvac167
• Goto R, Nianogo R, Okubo Y, Inoue K. (2022). Evaluation of Obesity Trends Among US Adolescents by Socioeconomic Status, 1999-2018. JAMA Pediatrics: 176(9), 937-940.
• Sawada R, Kondo N, Inoue K. (2022). Association between Income and Healthcare Utilization among US Adults at High Risk of CVD, 1999-2018. Endocrine Practice: 28(9), 921-922.
• Yazawa A, Shiba K, Inoue Y, Okuzono S, Inoue K, Kondo N, Kondo K, Kawachi I. (2022). Early childhood adversity and late-life depressive symptoms: unpacking mediation and interaction by adult socioeconomic status. Social Psychiatry and Psychiatric Epidemiology: 57(6), 1147-1156.
• Kanehara R, Goto A, Watanabe T, Inoue K, Taguri M, Kobayashi S, Imai K, Saito E, Katanoda K, Iwasaki M, Ohashi K, Noda M, Higashi T. (2022) Association Between Diabetes and Adjuvant Chemotherapy Implementation in Patients with Stage III Colorectal Cancer. J Diabetes Investig. doi: 10.1111/jdi.13837
• Yagome S, Sugiyama T, Inoue K, Igarashi A, Bouchi R, Ohsugi M, Ueki K, Goto A. (2022) Influence of the COVID-19 pandemic on overall physician visits and telemedicine use among patients with type 1 or type 2 diabetes in Japan. Journal of Epidemiology: JE20220032
• Ueda T, Tsurutani Y, Osada J, Inoue K, Hoshino Y, Ono M, Nakai K, Saito J, Yumoto K, Nishikawa T. (2022) Comparison of Echocardiographic Changes Between Surgery and Medication Treatment in Patients with Primary Aldosteronism. Journal of American Heart Associasion: 11(13):e023813.
• Tsai K, Inoue K, Mcclean M, Kaunitz JD, Akiba Y, Lee ML, Neverova NV, Currier JW, Ebrahimi R, Bashir MT, Leung AM. (2022) Iodine Contrast Exposure and Incident COVID-19 Infection. Frontiers in Medicine 9:1033601
• Kubo H, Tsurutani Y, Inoue K, Watanabe K, Yamazaki Y, Sunouchi T, Hoshino Y, Hirose R, Katsuragawa S, Tannai H, Shibahara Y, Kakuta Y, Matsui S, Saito J, Omura M, Sasano H, Nishikawa T. (2022) Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression. PLoS One;17(4):e0267732.
• Yoshihara A, Yoshimura Noh J, Inoue K, et al (19 authors). (2022) Prediction model of Graves' disease in general clinical practice based on complete blood count and biochemistry profile. Endocr J. doi: 10.1507/endocrj.EJ21-0741.
• Inoue K, Horwich T, Bhatnagar R, Bhatt K, Goldwater D, Seeman T, Watson KE. (2021). Urinary stress hormones, hypertension, and cardiovascular events: the Multi-Ethnic Study of Atherosclerosis. Hypertension: 78(5), 1640-1647.
• Inoue K, Tsugawa Y, Mangione CM, Duru OK. (2021). Association Between Industry Payments and Prescriptions of Long-acting Insulin: An Observational Study with Propensity-Score Matching. PLOS Medicine: 18(6), e1003645.
• Inoue K, Figueroa JF, DeJong CD, Tsugawa Y, Orav EJ, Shen C, Kazi DS. (2021). Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States.Circulation: Cardiovascular Quality and Outcomes: 14(5), e007521.
• Inoue K, Mayeda ER, Nianogo R, Paul K, Yu Y, Haan M, Ritz B. (2021). Estimating the joint effect of diabetes and subsequent depressive symptoms on mortality among older Mexican Americans. Annals of Epidemiology: 64, 120-126.
• Inoue K, Hsu W, Arah OA, Prosper A, Aberle D, Bui A. (2021). Generalizability and transportability of the results from randomized controlled trials: An example using the National Lung Screening Trial. Cancer Epidemiology, Biomarkers & Prevention: 30(12), 2227-2234.